Literature DB >> 27621438

CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.

Raphaël Bernard-Valnet1, Lidia Yshii1, Clémence Quériault1, Xuan-Hung Nguyen1, Sébastien Arthaud2, Magda Rodrigues1, Astrid Canivet1, Anne-Laure Morel2, Arthur Matthys1, Jan Bauer3, Béatrice Pignolet1, Yves Dauvilliers4, Christelle Peyron2, Roland S Liblau5.   

Abstract

Narcolepsy with cataplexy is a rare and severe sleep disorder caused by the destruction of orexinergic neurons in the lateral hypothalamus. The genetic and environmental factors associated with narcolepsy, together with serologic data, collectively point to an autoimmune origin. The current animal models of narcolepsy, based on either disruption of the orexinergic neurotransmission or neurons, do not allow study of the potential autoimmune etiology. Here, we sought to generate a mouse model that allows deciphering of the immune mechanisms leading to orexin(+) neuron loss and narcolepsy development. We generated mice expressing the hemagglutinin (HA) as a "neo-self-antigen" specifically in hypothalamic orexin(+) neurons (called Orex-HA), which were transferred with effector neo-self-antigen-specific T cells to assess whether an autoimmune process could be at play in narcolepsy. Given the tight association of narcolepsy with the human leukocyte antigen (HLA) HLA-DQB1*06:02 allele, we first tested the pathogenic contribution of CD4 Th1 cells. Although these T cells readily infiltrated the hypothalamus and triggered local inflammation, they did not elicit the loss of orexin(+) neurons or clinical manifestations of narcolepsy. In contrast, the transfer of cytotoxic CD8 T cells (CTLs) led to both T-cell infiltration and specific destruction of orexin(+) neurons. This phenotype was further aggravated upon repeated injections of CTLs. In situ, CTLs interacted directly with MHC class I-expressing orexin(+) neurons, resulting in cytolytic granule polarization toward neurons. Finally, drastic neuronal loss caused manifestations mimicking human narcolepsy, such as cataplexy and sleep attacks. This work demonstrates the potential role of CTLs as final effectors of the immunopathological process in narcolepsy.

Entities:  

Keywords:  CD8 T cells; autoimmunity; narcolepsy; orexin; sleep disorders

Mesh:

Substances:

Year:  2016        PMID: 27621438      PMCID: PMC5047186          DOI: 10.1073/pnas.1603325113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Michel Lecendreux; Christelle Monaca Charley; Patricia Franco; Xavier Drouot; Marie-Pia d'Ortho; Sandrine Launois; Séverine Lignot; Patrice Bourgin; Béatrice Nogues; Marc Rey; Sophie Bayard; Sabine Scholz; Sophie Lavault; Pascale Tubert-Bitter; Cristel Saussier; Antoine Pariente
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

3.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

4.  Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Authors:  Syed Sohail Ahmed; Wayne Volkmuth; José Duca; Lorenzo Corti; Michele Pallaoro; Alfredo Pezzicoli; Anette Karle; Fabio Rigat; Rino Rappuoli; Vas Narasimhan; Ilkka Julkunen; Arja Vuorela; Outi Vaarala; Hanna Nohynek; Franco Laghi Pasini; Emanuele Montomoli; Claudia Trombetta; Christopher M Adams; Jonathan Rothbard; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

5.  Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Authors:  Julie Cabarrocas; Jan Bauer; Eliane Piaggio; Roland Liblau; Hans Lassmann
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

6.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 7.  Control of arousal by the orexin neurons.

Authors:  Chloe Alexandre; Mark L Andermann; Thomas E Scammell
Journal:  Curr Opin Neurobiol       Date:  2013-05-15       Impact factor: 6.627

8.  AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Authors:  Hanna Nohynek; Jukka Jokinen; Markku Partinen; Outi Vaarala; Turkka Kirjavainen; Jonas Sundman; Sari-Leena Himanen; Christer Hublin; Ilkka Julkunen; Päivi Olsén; Outi Saarenpää-Heikkilä; Terhi Kilpi
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.

Authors:  D R Huang; J Wang; P Kivisakk; B J Rollins; R M Ransohoff
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells.

Authors:  Jasmin Herz; Kory R Johnson; Dorian B McGavern
Journal:  J Exp Med       Date:  2015-06-29       Impact factor: 14.307

View more
  36 in total

1.  Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.

Authors:  Kathryn Edwards; Germaine Hanquet; Steve Black; Emmanuel Mignot; Christopher Jankosky; Tom Shimabukuro; Elizabeth Miller; Hanna Nohynek; Pieter Neels
Journal:  Biologicals       Date:  2019-05-23       Impact factor: 1.856

Review 2.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

3.  Neuroimmunology: Waking the immune system.

Authors:  Sian Lewis
Journal:  Nat Rev Neurosci       Date:  2016-10-18       Impact factor: 34.870

4.  Put to sleep by immune cells.

Authors:  Roland S Liblau
Journal:  Nature       Date:  2018-10       Impact factor: 49.962

5.  T cells in patients with narcolepsy target self-antigens of hypocretin neurons.

Authors:  Daniela Latorre; Ulf Kallweit; Eric Armentani; Mathilde Foglierini; Federico Mele; Antonino Cassotta; Sandra Jovic; David Jarrossay; Johannes Mathis; Francesco Zellini; Burkhard Becher; Antonio Lanzavecchia; Ramin Khatami; Mauro Manconi; Mehdi Tafti; Claudio L Bassetti; Federica Sallusto
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

Review 6.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 7.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

Review 8.  Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis : Six new cases and a literature review.

Authors:  Ulf Kallweit; Claudio L A Bassetti; Michael Oberholzer; Rolf Fronczek; Mathieu Béguin; Matthias Strub; Gert Jan Lammers
Journal:  J Neurol       Date:  2018-07-04       Impact factor: 4.849

9.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Authors:  Cecilia S Lindestam Arlehamn; John Pham; Roy N Alcalay; April Frazier; Evan Shorr; Chelsea Carpenter; John Sidney; Rekha Dhanwani; Julian Agin-Liebes; Francesca Garretti; Amy W Amara; David G Standaert; Elizabeth J Phillips; Simon A Mallal; Bjoern Peters; David Sulzer; Alessandro Sette
Journal:  J Immunol       Date:  2019-05-13       Impact factor: 5.422

Review 10.  Autoimmunity in narcolepsy.

Authors:  Melodie Bonvalet; Hanna M Ollila; Aditya Ambati; Emmanuel Mignot
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.